Suppr超能文献

遗传研究对我们理解帕金森病的影响。

The impact of genetic research on our understanding of Parkinson's disease.

机构信息

NeuroRegeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Prog Brain Res. 2010;183:21-41. doi: 10.1016/S0079-6123(10)83002-X.

Abstract

Until recently, genetics was thought to play a minor role in the development of Parkinson's disease (PD). Over the last decade, a number of genes that definitively cause PD have been identified, which has led to the generation of disease models based on pathogenic gene variants that recapitulate many features of the disease. These genetic studies have provided novel insight into potential mechanisms underlying the aetiology of PD. This chapter will provide a profile of the genes conclusively linked to PD and will outline the mechanisms of PD pathogenesis implicated by genetic studies. Mitochondrial dysfunction, oxidative stress and impaired ubiquitin-proteasome system function are disease mechanisms that are particularly well supported by genetic studies and are therefore the focus of this chapter.

摘要

直到最近,遗传学被认为在帕金森病(PD)的发展中只起次要作用。在过去的十年中,已经确定了一些明确导致 PD 的基因,这导致了基于致病性基因突变体的疾病模型的产生,这些模型再现了疾病的许多特征。这些遗传研究为 PD 病因学的潜在机制提供了新的见解。本章将介绍与 PD 有明确关联的基因,并概述遗传研究中涉及的 PD 发病机制。线粒体功能障碍、氧化应激和泛素-蛋白酶体系统功能受损是遗传研究特别支持的疾病机制,因此是本章的重点。

相似文献

1
The impact of genetic research on our understanding of Parkinson's disease.
Prog Brain Res. 2010;183:21-41. doi: 10.1016/S0079-6123(10)83002-X.
2
Emerging pathways in genetic Parkinson's disease.
FEBS J. 2008 Dec;275(23):5747. doi: 10.1111/j.1742-4658.2008.06706.x.
3
Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Exp Neurol. 2009 Aug;218(2):235-46. doi: 10.1016/j.expneurol.2009.03.006. Epub 2009 Mar 18.
4
Genetics of Parkinson's disease and parkinsonism.
Expert Rev Neurother. 2007 Jun;7(6):657-66. doi: 10.1586/14737175.7.6.657.
5
Unravelling the role of defective genes.
Prog Brain Res. 2010;183:43-57. doi: 10.1016/S0079-6123(10)83003-1.
6
Parkinson's disease.
Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R183-94. doi: 10.1093/hmg/ddm159.
7
Pathogenic mutations in Parkinson disease.
Hum Mutat. 2007 Jul;28(7):641-53. doi: 10.1002/humu.20507.
8
Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
Parkinsonism Relat Disord. 2012 Jun;18(5):567-71. doi: 10.1016/j.parkreldis.2012.02.018. Epub 2012 Mar 24.
9
From genes to proteins in mendelian Parkinson's disease: an overview.
Anat Rec (Hoboken). 2009 Dec;292(12):1893-901. doi: 10.1002/ar.20968.
10
Genetics of Parkinson's disease and parkinsonism.
Ann Neurol. 2006 Oct;60(4):389-98. doi: 10.1002/ana.21022.

引用本文的文献

1
The Female Impact in the World of Neurodegeneration.
Front Integr Neurosci. 2021 Oct 6;15:750603. doi: 10.3389/fnint.2021.750603. eCollection 2021.
3
ATP13A2 Gene Variants in Patients with Parkinson's Disease in Xinjiang.
Biomed Res Int. 2020 Nov 30;2020:6954820. doi: 10.1155/2020/6954820. eCollection 2020.
5
Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins.
PLoS One. 2019 Apr 25;14(4):e0215277. doi: 10.1371/journal.pone.0215277. eCollection 2019.
7
Association between Parkinson's disease and G2019S and R1441C mutations of the LRRK2 gene.
Exp Ther Med. 2015 Oct;10(4):1450-1454. doi: 10.3892/etm.2015.2659. Epub 2015 Jul 27.
8
The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.
Cell Mol Biol Lett. 2014 Sep;19(3):407-37. doi: 10.2478/s11658-014-0205-5. Epub 2014 Aug 20.

本文引用的文献

3
Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization.
J Biol Chem. 2009 Dec 25;284(52):36346-36356. doi: 10.1074/jbc.M109.025437. Epub 2009 Oct 13.
4
Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease.
Parkinsonism Relat Disord. 2009 Dec;15(10):721-7. doi: 10.1016/j.parkreldis.2009.09.010. Epub 2009 Oct 7.
5
LRRK2 in Parkinson's disease: function in cells and neurodegeneration.
FEBS J. 2009 Nov;276(22):6436-44. doi: 10.1111/j.1742-4658.2009.07342.x. Epub 2009 Oct 5.
6
Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss.
Nat Neurosci. 2009 Sep;12(9):1129-35. doi: 10.1038/nn.2372. Epub 2009 Aug 16.
7
Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling.
FEBS J. 2009 Sep;276(18):5041-52. doi: 10.1111/j.1742-4658.2009.07201.x. Epub 2009 Aug 3.
8
Neuropathology of Lewy body disorders.
Brain Res Bull. 2009 Oct 28;80(4-5):203-10. doi: 10.1016/j.brainresbull.2009.06.018. Epub 2009 Jul 1.
9
Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.
ASN Neuro. 2009 Apr 14;1(1):e00002. doi: 10.1042/AN20090007.
10
The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro.
J Neurochem. 2009 May;109(4):959-68. doi: 10.1111/j.1471-4159.2009.06024.x. Epub 2009 Mar 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验